VP

Venkata Pavan Chand Jaladi

Active Director Director DIN 10469618
DIN 10469618 First appointment Jan 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Venkata Pavan Chand Jaladi

Data last updated:

Venkata Pavan Chand Jaladi is a Director at Insignia Pharma Private Limited (since 2024).

DIN 10469618
Primary Designation Director
First Appointment 18 Jan 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Insignia Pharma Private Limited U47721AP2024PTC113590
Director18 Jan 20242024Active

Board colleagues of Venkata Pavan Chand Jaladi

Directorship timeline

Open interactive timeline →
Insignia Pharma Private Limited
Premium access

Shareholding and investment profile for Venkata Pavan Chand Jaladi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Venkata Pavan Chand Jaladi

Venkata Pavan Chand Jaladi currently holds 1 directorship: Insignia Pharma Private Limited (Director, since 18 Jan 2024).

Venkata Pavan Chand Jaladi was first appointed on 18 Jan 2024 as Director at Insignia Pharma Private Limited.

The current boards of Venkata Pavan Chand Jaladi's companies include Sivakrishna Uppala (Insignia Pharma Private Limited), Sultana Naazneen (Insignia Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available